rFVIIIFc
LPS16473
Approved mab completed
Quick answer
rFVIIIFc for Hemophilia A With Inhibitors is a Approved program (mab) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pasteur
- Indication
- Hemophilia A With Inhibitors
- Phase
- Approved
- Modality
- mab
- Status
- completed